Aqtual (Series B)
Funding Details
Awarder
RSS - feeds.feedburner.com
Date Award
July 11, 2025
Vertical
Precision Medicine
Funding URL
View Funding Page
Funding Amount
$31,000,000
Company Info
Traction
Aqtual is moving towards the commercialization of its first flagship product: a therapy response prediction test in rheumatoid arthritis (RA).
Market
Chronic Diseases and Oncology
Location
Hayward, California, USA
Coinvestors
Bold Capital, Bold Longevity Growth Fund, Genoa Ventures, Manta Ray Ventures, Yu Galaxy
Company Description

Aqtual is a precision medicine company developing products for chronic disease management and oncology utilizing a novel cell-free DNA-based platform.

Links
Back to HomeBack to Precision Medicine DealsView Funding Announcement